The demise of the corporation, known as CPB, is a direct result of President Donald Trump's targeting of public media.

NeuroSense completed a Phase 2a clinical trial which met its safety and efficacy endpoints including reducing functional and ...

If you serve real human needs with relentless craft, your digital product can transcend “app” and become an advantage no one ...

EchoStar Corporation (NASDAQ: SATS), a global communications and connectivity provider, has selected MDA Space Ltd. (TSX: MDA ...

The global Energy Efficient Motor Market is anticipated to grow USD 72.06 billion by 2030 from an estimated USD 48.52 billion ...